nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—NPC1L1—macula lutea—glaucoma	0.241	0.965	CbGeAlD
Ezetimibe—CYP3A4—Pilocarpine—glaucoma	0.0265	0.166	CbGbCtD
Ezetimibe—ABCB1—Timolol—glaucoma	0.0254	0.159	CbGbCtD
Ezetimibe—ABCB1—Clonidine—glaucoma	0.0216	0.135	CbGbCtD
Ezetimibe—CYP3A4—Brinzolamide—glaucoma	0.0208	0.13	CbGbCtD
Ezetimibe—CYP3A4—Dorzolamide—glaucoma	0.0201	0.126	CbGbCtD
Ezetimibe—CYP3A4—Methazolamide—glaucoma	0.0179	0.112	CbGbCtD
Ezetimibe—CYP3A4—Acetazolamide—glaucoma	0.0143	0.0897	CbGbCtD
Ezetimibe—CYP3A4—Clonidine—glaucoma	0.013	0.0811	CbGbCtD
Ezetimibe—SOAT1—retina—glaucoma	0.00287	0.0115	CbGeAlD
Ezetimibe—SOAT1—connective tissue—glaucoma	0.00279	0.0112	CbGeAlD
Ezetimibe—ANPEP—connective tissue—glaucoma	0.00267	0.0107	CbGeAlD
Ezetimibe—Insomnia—Brinzolamide—glaucoma	0.000425	0.00119	CcSEcCtD
Ezetimibe—Muscle spasms—Clonidine—glaucoma	0.000425	0.00119	CcSEcCtD
Ezetimibe—Dyspnoea—Travoprost—glaucoma	0.000424	0.00119	CcSEcCtD
Ezetimibe—Paraesthesia—Brinzolamide—glaucoma	0.000422	0.00119	CcSEcCtD
Ezetimibe—Dyspepsia—Dorzolamide—glaucoma	0.000421	0.00118	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Timolol—glaucoma	0.000419	0.00118	CcSEcCtD
Ezetimibe—Dyspnoea—Brinzolamide—glaucoma	0.000419	0.00118	CcSEcCtD
Ezetimibe—Dyspepsia—Travoprost—glaucoma	0.000419	0.00118	CcSEcCtD
Ezetimibe—Asthenia—Apraclonidine—glaucoma	0.000418	0.00117	CcSEcCtD
Ezetimibe—Decreased appetite—Dorzolamide—glaucoma	0.000415	0.00117	CcSEcCtD
Ezetimibe—Erectile dysfunction—Timolol—glaucoma	0.000415	0.00117	CcSEcCtD
Ezetimibe—Urticaria—Acetazolamide—glaucoma	0.000414	0.00116	CcSEcCtD
Ezetimibe—Dyspepsia—Brinzolamide—glaucoma	0.000414	0.00116	CcSEcCtD
Ezetimibe—Pruritus—Apraclonidine—glaucoma	0.000412	0.00116	CcSEcCtD
Ezetimibe—Body temperature increased—Acetazolamide—glaucoma	0.000412	0.00116	CcSEcCtD
Ezetimibe—Fatigue—Dorzolamide—glaucoma	0.000412	0.00116	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000411	0.00116	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Travoprost—glaucoma	0.000411	0.00115	CcSEcCtD
Ezetimibe—Fatigue—Travoprost—glaucoma	0.00041	0.00115	CcSEcCtD
Ezetimibe—Flushing—Betaxolol—glaucoma	0.00041	0.00115	CcSEcCtD
Ezetimibe—Ill-defined disorder—Clonidine—glaucoma	0.00041	0.00115	CcSEcCtD
Ezetimibe—Pain—Dorzolamide—glaucoma	0.000409	0.00115	CcSEcCtD
Ezetimibe—Insomnia—Pilocarpine—glaucoma	0.000408	0.00115	CcSEcCtD
Ezetimibe—Decreased appetite—Brinzolamide—glaucoma	0.000408	0.00115	CcSEcCtD
Ezetimibe—Pain—Travoprost—glaucoma	0.000407	0.00114	CcSEcCtD
Ezetimibe—Constipation—Travoprost—glaucoma	0.000407	0.00114	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000406	0.00114	CcSEcCtD
Ezetimibe—Paraesthesia—Pilocarpine—glaucoma	0.000405	0.00114	CcSEcCtD
Ezetimibe—Asthenia—Bimatoprost—glaucoma	0.000405	0.00114	CcSEcCtD
Ezetimibe—Fatigue—Brinzolamide—glaucoma	0.000405	0.00114	CcSEcCtD
Ezetimibe—Angioedema—Clonidine—glaucoma	0.000404	0.00113	CcSEcCtD
Ezetimibe—Dyspnoea—Pilocarpine—glaucoma	0.000403	0.00113	CcSEcCtD
Ezetimibe—Pain—Brinzolamide—glaucoma	0.000402	0.00113	CcSEcCtD
Ezetimibe—Angiopathy—Betaxolol—glaucoma	0.000401	0.00113	CcSEcCtD
Ezetimibe—Pruritus—Bimatoprost—glaucoma	0.0004	0.00112	CcSEcCtD
Ezetimibe—Immune system disorder—Betaxolol—glaucoma	0.000399	0.00112	CcSEcCtD
Ezetimibe—Diarrhoea—Apraclonidine—glaucoma	0.000399	0.00112	CcSEcCtD
Ezetimibe—Malaise—Clonidine—glaucoma	0.000398	0.00112	CcSEcCtD
Ezetimibe—Mediastinal disorder—Betaxolol—glaucoma	0.000398	0.00112	CcSEcCtD
Ezetimibe—Dyspepsia—Pilocarpine—glaucoma	0.000397	0.00112	CcSEcCtD
Ezetimibe—Feeling abnormal—Dorzolamide—glaucoma	0.000394	0.00111	CcSEcCtD
Ezetimibe—ABCB1—retina—glaucoma	0.000393	0.00157	CbGeAlD
Ezetimibe—Decreased appetite—Pilocarpine—glaucoma	0.000393	0.0011	CcSEcCtD
Ezetimibe—Feeling abnormal—Travoprost—glaucoma	0.000392	0.0011	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Dorzolamide—glaucoma	0.000391	0.0011	CcSEcCtD
Ezetimibe—Alopecia—Betaxolol—glaucoma	0.00039	0.0011	CcSEcCtD
Ezetimibe—Palpitations—Clonidine—glaucoma	0.00039	0.0011	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00039	0.0011	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Travoprost—glaucoma	0.000389	0.00109	CcSEcCtD
Ezetimibe—Feeling abnormal—Brinzolamide—glaucoma	0.000387	0.00109	CcSEcCtD
Ezetimibe—Mental disorder—Betaxolol—glaucoma	0.000387	0.00109	CcSEcCtD
Ezetimibe—Pain—Pilocarpine—glaucoma	0.000386	0.00108	CcSEcCtD
Ezetimibe—Constipation—Pilocarpine—glaucoma	0.000386	0.00108	CcSEcCtD
Ezetimibe—Cough—Clonidine—glaucoma	0.000386	0.00108	CcSEcCtD
Ezetimibe—Dizziness—Apraclonidine—glaucoma	0.000385	0.00108	CcSEcCtD
Ezetimibe—Erythema—Betaxolol—glaucoma	0.000385	0.00108	CcSEcCtD
Ezetimibe—Malnutrition—Betaxolol—glaucoma	0.000385	0.00108	CcSEcCtD
Ezetimibe—Urticaria—Dorzolamide—glaucoma	0.00038	0.00107	CcSEcCtD
Ezetimibe—Body temperature increased—Dorzolamide—glaucoma	0.000378	0.00106	CcSEcCtD
Ezetimibe—Abdominal pain—Dorzolamide—glaucoma	0.000378	0.00106	CcSEcCtD
Ezetimibe—Sinusitis—Timolol—glaucoma	0.000377	0.00106	CcSEcCtD
Ezetimibe—Chest pain—Clonidine—glaucoma	0.000376	0.00106	CcSEcCtD
Ezetimibe—Arthralgia—Clonidine—glaucoma	0.000376	0.00106	CcSEcCtD
Ezetimibe—Abdominal pain—Travoprost—glaucoma	0.000376	0.00106	CcSEcCtD
Ezetimibe—Asthenia—Acetazolamide—glaucoma	0.000374	0.00105	CcSEcCtD
Ezetimibe—Dizziness—Bimatoprost—glaucoma	0.000374	0.00105	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000374	0.00105	CcSEcCtD
Ezetimibe—Urticaria—Brinzolamide—glaucoma	0.000373	0.00105	CcSEcCtD
Ezetimibe—Feeling abnormal—Pilocarpine—glaucoma	0.000372	0.00105	CcSEcCtD
Ezetimibe—Discomfort—Clonidine—glaucoma	0.000372	0.00104	CcSEcCtD
Ezetimibe—Vomiting—Apraclonidine—glaucoma	0.000371	0.00104	CcSEcCtD
Ezetimibe—Muscle spasms—Betaxolol—glaucoma	0.00037	0.00104	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Pilocarpine—glaucoma	0.000369	0.00104	CcSEcCtD
Ezetimibe—Hypersensitivity—Brimonidine—glaucoma	0.000369	0.00104	CcSEcCtD
Ezetimibe—Dry mouth—Clonidine—glaucoma	0.000368	0.00103	CcSEcCtD
Ezetimibe—Dermatitis—Apraclonidine—glaucoma	0.000367	0.00103	CcSEcCtD
Ezetimibe—Headache—Apraclonidine—glaucoma	0.000365	0.00103	CcSEcCtD
Ezetimibe—Confusional state—Clonidine—glaucoma	0.000364	0.00102	CcSEcCtD
Ezetimibe—Asthenia—Brimonidine—glaucoma	0.000359	0.00101	CcSEcCtD
Ezetimibe—Infection—Clonidine—glaucoma	0.000358	0.00101	CcSEcCtD
Ezetimibe—Abdominal pain—Pilocarpine—glaucoma	0.000357	0.001	CcSEcCtD
Ezetimibe—Body temperature increased—Pilocarpine—glaucoma	0.000357	0.001	CcSEcCtD
Ezetimibe—Ill-defined disorder—Betaxolol—glaucoma	0.000357	0.001	CcSEcCtD
Ezetimibe—Diarrhoea—Acetazolamide—glaucoma	0.000357	0.001	CcSEcCtD
Ezetimibe—Rash—Bimatoprost—glaucoma	0.000356	0.001	CcSEcCtD
Ezetimibe—Dermatitis—Bimatoprost—glaucoma	0.000356	0.001	CcSEcCtD
Ezetimibe—Oedema peripheral—Timolol—glaucoma	0.000356	0.000999	CcSEcCtD
Ezetimibe—Anaemia—Betaxolol—glaucoma	0.000356	0.000999	CcSEcCtD
Ezetimibe—Connective tissue disorder—Timolol—glaucoma	0.000355	0.000997	CcSEcCtD
Ezetimibe—Pruritus—Brimonidine—glaucoma	0.000354	0.000995	CcSEcCtD
Ezetimibe—Headache—Bimatoprost—glaucoma	0.000354	0.000995	CcSEcCtD
Ezetimibe—Nervous system disorder—Clonidine—glaucoma	0.000354	0.000994	CcSEcCtD
Ezetimibe—Thrombocytopenia—Clonidine—glaucoma	0.000353	0.000992	CcSEcCtD
Ezetimibe—Hypersensitivity—Dorzolamide—glaucoma	0.000352	0.000989	CcSEcCtD
Ezetimibe—Hypersensitivity—Travoprost—glaucoma	0.000351	0.000985	CcSEcCtD
Ezetimibe—Skin disorder—Clonidine—glaucoma	0.00035	0.000984	CcSEcCtD
Ezetimibe—Malaise—Betaxolol—glaucoma	0.000347	0.000975	CcSEcCtD
Ezetimibe—Nausea—Apraclonidine—glaucoma	0.000346	0.000973	CcSEcCtD
Ezetimibe—Hypersensitivity—Brinzolamide—glaucoma	0.000346	0.000973	CcSEcCtD
Ezetimibe—Dizziness—Acetazolamide—glaucoma	0.000345	0.000969	CcSEcCtD
Ezetimibe—Asthenia—Dorzolamide—glaucoma	0.000343	0.000963	CcSEcCtD
Ezetimibe—Asthenia—Travoprost—glaucoma	0.000341	0.000959	CcSEcCtD
Ezetimibe—Palpitations—Betaxolol—glaucoma	0.00034	0.000955	CcSEcCtD
Ezetimibe—Pruritus—Dorzolamide—glaucoma	0.000338	0.00095	CcSEcCtD
Ezetimibe—Asthenia—Brinzolamide—glaucoma	0.000337	0.000947	CcSEcCtD
Ezetimibe—Pruritus—Travoprost—glaucoma	0.000337	0.000946	CcSEcCtD
Ezetimibe—Cough—Betaxolol—glaucoma	0.000336	0.000943	CcSEcCtD
Ezetimibe—Nausea—Bimatoprost—glaucoma	0.000336	0.000943	CcSEcCtD
Ezetimibe—Hypersensitivity—Pilocarpine—glaucoma	0.000333	0.000935	CcSEcCtD
Ezetimibe—Pruritus—Brinzolamide—glaucoma	0.000332	0.000934	CcSEcCtD
Ezetimibe—Vomiting—Acetazolamide—glaucoma	0.000331	0.000931	CcSEcCtD
Ezetimibe—Dizziness—Brimonidine—glaucoma	0.000331	0.00093	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Clonidine—glaucoma	0.000329	0.000923	CcSEcCtD
Ezetimibe—Angiopathy—Timolol—glaucoma	0.000328	0.00092	CcSEcCtD
Ezetimibe—Chest pain—Betaxolol—glaucoma	0.000327	0.00092	CcSEcCtD
Ezetimibe—Arthralgia—Betaxolol—glaucoma	0.000327	0.00092	CcSEcCtD
Ezetimibe—Myalgia—Betaxolol—glaucoma	0.000327	0.00092	CcSEcCtD
Ezetimibe—Diarrhoea—Dorzolamide—glaucoma	0.000327	0.000919	CcSEcCtD
Ezetimibe—Headache—Acetazolamide—glaucoma	0.000327	0.000918	CcSEcCtD
Ezetimibe—Insomnia—Clonidine—glaucoma	0.000326	0.000916	CcSEcCtD
Ezetimibe—Immune system disorder—Timolol—glaucoma	0.000326	0.000916	CcSEcCtD
Ezetimibe—Diarrhoea—Travoprost—glaucoma	0.000326	0.000915	CcSEcCtD
Ezetimibe—Mediastinal disorder—Timolol—glaucoma	0.000325	0.000914	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000325	0.000914	CcSEcCtD
Ezetimibe—Asthenia—Pilocarpine—glaucoma	0.000324	0.00091	CcSEcCtD
Ezetimibe—Paraesthesia—Clonidine—glaucoma	0.000324	0.00091	CcSEcCtD
Ezetimibe—Discomfort—Betaxolol—glaucoma	0.000324	0.000909	CcSEcCtD
Ezetimibe—Dyspnoea—Clonidine—glaucoma	0.000321	0.000903	CcSEcCtD
Ezetimibe—Diarrhoea—Brinzolamide—glaucoma	0.000321	0.000903	CcSEcCtD
Ezetimibe—Dry mouth—Betaxolol—glaucoma	0.00032	0.0009	CcSEcCtD
Ezetimibe—Pruritus—Pilocarpine—glaucoma	0.000319	0.000898	CcSEcCtD
Ezetimibe—Alopecia—Timolol—glaucoma	0.000319	0.000896	CcSEcCtD
Ezetimibe—Confusional state—Betaxolol—glaucoma	0.000317	0.000889	CcSEcCtD
Ezetimibe—Mental disorder—Timolol—glaucoma	0.000316	0.000889	CcSEcCtD
Ezetimibe—Dizziness—Dorzolamide—glaucoma	0.000316	0.000888	CcSEcCtD
Ezetimibe—Rash—Brimonidine—glaucoma	0.000315	0.000886	CcSEcCtD
Ezetimibe—Dermatitis—Brimonidine—glaucoma	0.000315	0.000886	CcSEcCtD
Ezetimibe—Dizziness—Travoprost—glaucoma	0.000315	0.000884	CcSEcCtD
Ezetimibe—Erythema—Timolol—glaucoma	0.000314	0.000883	CcSEcCtD
Ezetimibe—Malnutrition—Timolol—glaucoma	0.000314	0.000883	CcSEcCtD
Ezetimibe—Headache—Brimonidine—glaucoma	0.000313	0.000881	CcSEcCtD
Ezetimibe—Decreased appetite—Clonidine—glaucoma	0.000313	0.000881	CcSEcCtD
Ezetimibe—Infection—Betaxolol—glaucoma	0.000312	0.000876	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Clonidine—glaucoma	0.000311	0.000875	CcSEcCtD
Ezetimibe—Fatigue—Clonidine—glaucoma	0.000311	0.000874	CcSEcCtD
Ezetimibe—Dizziness—Brinzolamide—glaucoma	0.000311	0.000873	CcSEcCtD
Ezetimibe—Nausea—Acetazolamide—glaucoma	0.00031	0.00087	CcSEcCtD
Ezetimibe—Diarrhoea—Pilocarpine—glaucoma	0.000309	0.000868	CcSEcCtD
Ezetimibe—Pain—Clonidine—glaucoma	0.000308	0.000866	CcSEcCtD
Ezetimibe—Constipation—Clonidine—glaucoma	0.000308	0.000866	CcSEcCtD
Ezetimibe—Nervous system disorder—Betaxolol—glaucoma	0.000308	0.000865	CcSEcCtD
Ezetimibe—Thrombocytopenia—Betaxolol—glaucoma	0.000307	0.000864	CcSEcCtD
Ezetimibe—Skin disorder—Betaxolol—glaucoma	0.000305	0.000857	CcSEcCtD
Ezetimibe—Vomiting—Dorzolamide—glaucoma	0.000304	0.000854	CcSEcCtD
Ezetimibe—Rash—Dorzolamide—glaucoma	0.000301	0.000847	CcSEcCtD
Ezetimibe—Dermatitis—Dorzolamide—glaucoma	0.000301	0.000846	CcSEcCtD
Ezetimibe—Rash—Travoprost—glaucoma	0.0003	0.000843	CcSEcCtD
Ezetimibe—Dermatitis—Travoprost—glaucoma	0.0003	0.000842	CcSEcCtD
Ezetimibe—Headache—Dorzolamide—glaucoma	0.000299	0.000841	CcSEcCtD
Ezetimibe—Vomiting—Brinzolamide—glaucoma	0.000299	0.000839	CcSEcCtD
Ezetimibe—Dizziness—Pilocarpine—glaucoma	0.000299	0.000839	CcSEcCtD
Ezetimibe—Headache—Travoprost—glaucoma	0.000298	0.000838	CcSEcCtD
Ezetimibe—Nausea—Brimonidine—glaucoma	0.000297	0.000835	CcSEcCtD
Ezetimibe—Feeling abnormal—Clonidine—glaucoma	0.000297	0.000835	CcSEcCtD
Ezetimibe—Rash—Brinzolamide—glaucoma	0.000296	0.000832	CcSEcCtD
Ezetimibe—Dermatitis—Brinzolamide—glaucoma	0.000296	0.000832	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Clonidine—glaucoma	0.000295	0.000828	CcSEcCtD
Ezetimibe—Headache—Brinzolamide—glaucoma	0.000294	0.000827	CcSEcCtD
Ezetimibe—Angioedema—Timolol—glaucoma	0.000287	0.000807	CcSEcCtD
Ezetimibe—Vomiting—Pilocarpine—glaucoma	0.000287	0.000807	CcSEcCtD
Ezetimibe—Urticaria—Clonidine—glaucoma	0.000286	0.000805	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000286	0.000804	CcSEcCtD
Ezetimibe—Abdominal pain—Clonidine—glaucoma	0.000285	0.000801	CcSEcCtD
Ezetimibe—Body temperature increased—Clonidine—glaucoma	0.000285	0.000801	CcSEcCtD
Ezetimibe—Rash—Pilocarpine—glaucoma	0.000285	0.0008	CcSEcCtD
Ezetimibe—Dermatitis—Pilocarpine—glaucoma	0.000284	0.000799	CcSEcCtD
Ezetimibe—Insomnia—Betaxolol—glaucoma	0.000284	0.000798	CcSEcCtD
Ezetimibe—Nausea—Dorzolamide—glaucoma	0.000284	0.000798	CcSEcCtD
Ezetimibe—Headache—Pilocarpine—glaucoma	0.000283	0.000795	CcSEcCtD
Ezetimibe—Nausea—Travoprost—glaucoma	0.000283	0.000794	CcSEcCtD
Ezetimibe—Paraesthesia—Betaxolol—glaucoma	0.000282	0.000792	CcSEcCtD
Ezetimibe—Dyspnoea—Betaxolol—glaucoma	0.00028	0.000786	CcSEcCtD
Ezetimibe—Nausea—Brinzolamide—glaucoma	0.000279	0.000784	CcSEcCtD
Ezetimibe—Palpitations—Timolol—glaucoma	0.000278	0.00078	CcSEcCtD
Ezetimibe—Dyspepsia—Betaxolol—glaucoma	0.000276	0.000776	CcSEcCtD
Ezetimibe—Cough—Timolol—glaucoma	0.000274	0.00077	CcSEcCtD
Ezetimibe—Decreased appetite—Betaxolol—glaucoma	0.000273	0.000767	CcSEcCtD
Ezetimibe—Hypertension—Timolol—glaucoma	0.000271	0.000762	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Betaxolol—glaucoma	0.000271	0.000762	CcSEcCtD
Ezetimibe—Fatigue—Betaxolol—glaucoma	0.000271	0.00076	CcSEcCtD
Ezetimibe—Constipation—Betaxolol—glaucoma	0.000268	0.000754	CcSEcCtD
Ezetimibe—Pain—Betaxolol—glaucoma	0.000268	0.000754	CcSEcCtD
Ezetimibe—Nausea—Pilocarpine—glaucoma	0.000268	0.000754	CcSEcCtD
Ezetimibe—Arthralgia—Timolol—glaucoma	0.000268	0.000752	CcSEcCtD
Ezetimibe—Myalgia—Timolol—glaucoma	0.000268	0.000752	CcSEcCtD
Ezetimibe—Chest pain—Timolol—glaucoma	0.000268	0.000752	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000266	0.000747	CcSEcCtD
Ezetimibe—Hypersensitivity—Clonidine—glaucoma	0.000266	0.000746	CcSEcCtD
Ezetimibe—Discomfort—Timolol—glaucoma	0.000264	0.000743	CcSEcCtD
Ezetimibe—Dry mouth—Timolol—glaucoma	0.000262	0.000735	CcSEcCtD
Ezetimibe—Asthenia—Clonidine—glaucoma	0.000259	0.000727	CcSEcCtD
Ezetimibe—Feeling abnormal—Betaxolol—glaucoma	0.000259	0.000727	CcSEcCtD
Ezetimibe—Confusional state—Timolol—glaucoma	0.000259	0.000727	CcSEcCtD
Ezetimibe—Anaphylactic shock—Timolol—glaucoma	0.000256	0.000721	CcSEcCtD
Ezetimibe—Pruritus—Clonidine—glaucoma	0.000255	0.000717	CcSEcCtD
Ezetimibe—Infection—Timolol—glaucoma	0.000255	0.000716	CcSEcCtD
Ezetimibe—Nervous system disorder—Timolol—glaucoma	0.000252	0.000707	CcSEcCtD
Ezetimibe—Urticaria—Betaxolol—glaucoma	0.000249	0.000701	CcSEcCtD
Ezetimibe—Skin disorder—Timolol—glaucoma	0.000249	0.0007	CcSEcCtD
Ezetimibe—Body temperature increased—Betaxolol—glaucoma	0.000248	0.000697	CcSEcCtD
Ezetimibe—Diarrhoea—Clonidine—glaucoma	0.000247	0.000693	CcSEcCtD
Ezetimibe—Dizziness—Clonidine—glaucoma	0.000238	0.00067	CcSEcCtD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000234	0.000999	CbGpPWpGaD
Ezetimibe—Musculoskeletal discomfort—Timolol—glaucoma	0.000234	0.000657	CcSEcCtD
Ezetimibe—Insomnia—Timolol—glaucoma	0.000232	0.000652	CcSEcCtD
Ezetimibe—Hypersensitivity—Betaxolol—glaucoma	0.000231	0.00065	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—TXN—glaucoma	0.000231	0.000984	CbGpPWpGaD
Ezetimibe—Paraesthesia—Timolol—glaucoma	0.00023	0.000647	CcSEcCtD
Ezetimibe—UGT1A3—Metabolism—CA5A—glaucoma	0.00023	0.00098	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—NARFL—glaucoma	0.00023	0.00098	CbGpPWpGaD
Ezetimibe—Vomiting—Clonidine—glaucoma	0.000229	0.000644	CcSEcCtD
Ezetimibe—Dyspnoea—Timolol—glaucoma	0.000229	0.000642	CcSEcCtD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.000228	0.000974	CbGpPWpGaD
Ezetimibe—Rash—Clonidine—glaucoma	0.000227	0.000639	CcSEcCtD
Ezetimibe—Dermatitis—Clonidine—glaucoma	0.000227	0.000638	CcSEcCtD
Ezetimibe—UGT1A1—Biological oxidations—GSTT1—glaucoma	0.000227	0.000966	CbGpPWpGaD
Ezetimibe—Headache—Clonidine—glaucoma	0.000226	0.000635	CcSEcCtD
Ezetimibe—Dyspepsia—Timolol—glaucoma	0.000226	0.000634	CcSEcCtD
Ezetimibe—Asthenia—Betaxolol—glaucoma	0.000225	0.000633	CcSEcCtD
Ezetimibe—ABCC3—Fluoropyrimidine Activity—TP53—glaucoma	0.000223	0.000952	CbGpPWpGaD
Ezetimibe—Decreased appetite—Timolol—glaucoma	0.000223	0.000626	CcSEcCtD
Ezetimibe—UGT2B7—Biological oxidations—CYP1B1—glaucoma	0.000222	0.000947	CbGpPWpGaD
Ezetimibe—Pruritus—Betaxolol—glaucoma	0.000222	0.000624	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Timolol—glaucoma	0.000221	0.000622	CcSEcCtD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000221	0.000944	CbGpPWpGaD
Ezetimibe—Fatigue—Timolol—glaucoma	0.000221	0.000621	CcSEcCtD
Ezetimibe—Pain—Timolol—glaucoma	0.000219	0.000616	CcSEcCtD
Ezetimibe—UGT2B7—Metapathway biotransformation—CYP1B1—glaucoma	0.000219	0.000934	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000219	0.000933	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000217	0.000924	CbGpPWpGaD
Ezetimibe—Diarrhoea—Betaxolol—glaucoma	0.000215	0.000604	CcSEcCtD
Ezetimibe—Nausea—Clonidine—glaucoma	0.000214	0.000602	CcSEcCtD
Ezetimibe—Feeling abnormal—Timolol—glaucoma	0.000211	0.000594	CcSEcCtD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000211	0.000898	CbGpPWpGaD
Ezetimibe—Gastrointestinal pain—Timolol—glaucoma	0.00021	0.000589	CcSEcCtD
Ezetimibe—UGT2B15—Metabolism—CA1—glaucoma	0.00021	0.000894	CbGpPWpGaD
Ezetimibe—UGT1A3—Biological oxidations—GSTM1—glaucoma	0.000209	0.000891	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000209	0.00089	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000208	0.000885	CbGpPWpGaD
Ezetimibe—Dizziness—Betaxolol—glaucoma	0.000208	0.000583	CcSEcCtD
Ezetimibe—UGT1A3—Metapathway biotransformation—GSTM1—glaucoma	0.000206	0.000879	CbGpPWpGaD
Ezetimibe—Urticaria—Timolol—glaucoma	0.000204	0.000572	CcSEcCtD
Ezetimibe—UGT2B15—Metabolism—CTSA—glaucoma	0.000203	0.000865	CbGpPWpGaD
Ezetimibe—Body temperature increased—Timolol—glaucoma	0.000203	0.00057	CcSEcCtD
Ezetimibe—Abdominal pain—Timolol—glaucoma	0.000203	0.00057	CcSEcCtD
Ezetimibe—ABCC3—NRF2 pathway—GSTM1—glaucoma	0.000203	0.000864	CbGpPWpGaD
Ezetimibe—UGT2B7—NRF2 pathway—GSTM1—glaucoma	0.000203	0.000864	CbGpPWpGaD
Ezetimibe—Vomiting—Betaxolol—glaucoma	0.0002	0.000561	CcSEcCtD
Ezetimibe—ABCG2—HIF-2-alpha transcription factor network—VEGFA—glaucoma	0.000199	0.000848	CbGpPWpGaD
Ezetimibe—Rash—Betaxolol—glaucoma	0.000198	0.000556	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.000198	0.000843	CbGpPWpGaD
Ezetimibe—Dermatitis—Betaxolol—glaucoma	0.000198	0.000556	CcSEcCtD
Ezetimibe—Headache—Betaxolol—glaucoma	0.000197	0.000553	CcSEcCtD
Ezetimibe—ABCC3—Metabolism—CA5A—glaucoma	0.000195	0.000833	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—NARFL—glaucoma	0.000195	0.000833	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—ABCA1—glaucoma	0.000195	0.000833	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—CYP1B1—glaucoma	0.000195	0.000833	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CA5A—glaucoma	0.000195	0.000833	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—NARFL—glaucoma	0.000195	0.000833	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—CA2—glaucoma	0.000192	0.000817	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00019	0.00081	CbGpPWpGaD
Ezetimibe—Hypersensitivity—Timolol—glaucoma	0.000189	0.000531	CcSEcCtD
Ezetimibe—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000187	0.000796	CbGpPWpGaD
Ezetimibe—Nausea—Betaxolol—glaucoma	0.000186	0.000524	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—GSTT1—glaucoma	0.000186	0.000793	CbGpPWpGaD
Ezetimibe—Asthenia—Timolol—glaucoma	0.000184	0.000517	CcSEcCtD
Ezetimibe—ANPEP—Metabolism of proteins—MMP1—glaucoma	0.000182	0.000774	CbGpPWpGaD
Ezetimibe—Pruritus—Timolol—glaucoma	0.000181	0.00051	CcSEcCtD
Ezetimibe—UGT1A1—Biological oxidations—CYP1B1—glaucoma	0.000181	0.00077	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—GSTT1—glaucoma	0.000179	0.000763	CbGpPWpGaD
Ezetimibe—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000179	0.000761	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000178	0.000761	CbGpPWpGaD
Ezetimibe—UGT1A1—Metapathway biotransformation—CYP1B1—glaucoma	0.000178	0.000759	CbGpPWpGaD
Ezetimibe—UGT2B7—Biological oxidations—GSTM1—glaucoma	0.000178	0.000757	CbGpPWpGaD
Ezetimibe—Diarrhoea—Timolol—glaucoma	0.000175	0.000493	CcSEcCtD
Ezetimibe—UGT2B7—Metapathway biotransformation—GSTM1—glaucoma	0.000175	0.000747	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000172	0.000731	CbGpPWpGaD
Ezetimibe—Dizziness—Timolol—glaucoma	0.00017	0.000477	CcSEcCtD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000165	0.000705	CbGpPWpGaD
Ezetimibe—UGT1A1—NRF2 pathway—GSTM1—glaucoma	0.000165	0.000702	CbGpPWpGaD
Ezetimibe—Vomiting—Timolol—glaucoma	0.000163	0.000458	CcSEcCtD
Ezetimibe—Rash—Timolol—glaucoma	0.000162	0.000454	CcSEcCtD
Ezetimibe—Dermatitis—Timolol—glaucoma	0.000162	0.000454	CcSEcCtD
Ezetimibe—Headache—Timolol—glaucoma	0.000161	0.000451	CcSEcCtD
Ezetimibe—ABCC2—NRF2 pathway—GSTM1—glaucoma	0.000161	0.000685	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00016	0.000682	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—NARFL—glaucoma	0.000159	0.000677	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CA5A—glaucoma	0.000159	0.000677	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.000158	0.000673	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—GSTM1—glaucoma	0.000156	0.000666	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000155	0.000659	CbGpPWpGaD
Ezetimibe—ABCG2—Fluoropyrimidine Activity—TP53—glaucoma	0.000154	0.000656	CbGpPWpGaD
Ezetimibe—Nausea—Timolol—glaucoma	0.000152	0.000428	CcSEcCtD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.00015	0.000639	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—CYP1B1—glaucoma	0.000148	0.000632	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—ABCA1—glaucoma	0.000148	0.000632	CbGpPWpGaD
Ezetimibe—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000147	0.000625	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—NARFL—glaucoma	0.000146	0.000621	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CA5A—glaucoma	0.000146	0.000621	CbGpPWpGaD
Ezetimibe—UGT1A1—Biological oxidations—GSTM1—glaucoma	0.000144	0.000615	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.000144	0.000615	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000144	0.000615	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—ABCA1—glaucoma	0.000143	0.000608	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—CYP1B1—glaucoma	0.000143	0.000608	CbGpPWpGaD
Ezetimibe—UGT1A1—Metapathway biotransformation—GSTM1—glaucoma	0.000142	0.000607	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—MMP2—glaucoma	0.000141	0.000599	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—MTHFR—glaucoma	0.000138	0.000589	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—TXN—glaucoma	0.000135	0.000576	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CA5A—glaucoma	0.000135	0.000575	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—NARFL—glaucoma	0.000135	0.000575	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000132	0.000564	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—APOE—glaucoma	0.000129	0.000548	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—CAV1—glaucoma	0.000127	0.000543	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000127	0.000541	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL1A—glaucoma	0.000124	0.000529	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000119	0.000508	CbGpPWpGaD
Ezetimibe—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000119	0.000505	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—GSTM1—glaucoma	0.000118	0.000505	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000117	0.000499	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—VEGFA—glaucoma	0.000117	0.000499	CbGpPWpGaD
Ezetimibe—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000117	0.000499	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—GSTM1—glaucoma	0.000114	0.000486	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CA1—glaucoma	0.000112	0.000479	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—FAS—glaucoma	0.000111	0.000472	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00011	0.00047	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—C3—glaucoma	0.000109	0.000465	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CTSA—glaucoma	0.000109	0.000464	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GSTT1—glaucoma	0.000105	0.000446	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—MTHFR—glaucoma	0.000105	0.000446	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CA2—glaucoma	0.000103	0.000438	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—MTHFR—glaucoma	0.000101	0.00043	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—APOE—glaucoma	9.74e-05	0.000415	CbGpPWpGaD
Ezetimibe—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	9.66e-05	0.000412	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—CAV1—glaucoma	9.65e-05	0.000412	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—NOS3—glaucoma	9.63e-05	0.000411	CbGpPWpGaD
Ezetimibe—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	9.61e-05	0.00041	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CA1—glaucoma	9.55e-05	0.000407	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CA1—glaucoma	9.55e-05	0.000407	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—APOE—glaucoma	9.38e-05	0.0004	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	9.35e-05	0.000398	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—CAV1—glaucoma	9.29e-05	0.000396	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC6A1—glaucoma	9.28e-05	0.000396	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CTSA—glaucoma	9.25e-05	0.000394	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CTSA—glaucoma	9.25e-05	0.000394	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	8.94e-05	0.000381	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PTGS2—glaucoma	8.81e-05	0.000376	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CA2—glaucoma	8.73e-05	0.000372	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CA2—glaucoma	8.73e-05	0.000372	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.72e-05	0.000372	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	8.53e-05	0.000364	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	8.53e-05	0.000364	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—ABCA1—glaucoma	8.34e-05	0.000356	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—CYP1B1—glaucoma	8.34e-05	0.000356	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.07e-05	0.000344	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CA1—glaucoma	7.76e-05	0.000331	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CTSA—glaucoma	7.51e-05	0.00032	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—NOS3—glaucoma	7.3e-05	0.000311	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NARFL—glaucoma	7.29e-05	0.000311	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CA5A—glaucoma	7.29e-05	0.000311	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—TXN—glaucoma	7.23e-05	0.000308	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CA1—glaucoma	7.11e-05	0.000303	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CA2—glaucoma	7.09e-05	0.000302	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—NOS3—glaucoma	7.03e-05	0.0003	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	6.97e-05	0.000297	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CTSA—glaucoma	6.88e-05	0.000294	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PTGS2—glaucoma	6.68e-05	0.000285	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GSTM1—glaucoma	6.67e-05	0.000284	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CA1—glaucoma	6.58e-05	0.000281	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CA2—glaucoma	6.5e-05	0.000277	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PTGS2—glaucoma	6.43e-05	0.000274	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	6.42e-05	0.000274	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—GSTT1—glaucoma	6.41e-05	0.000273	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	6.38e-05	0.000272	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CTSA—glaucoma	6.37e-05	0.000272	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.35e-05	0.000271	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.35e-05	0.000271	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	6.33e-05	0.00027	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—TXN—glaucoma	6.15e-05	0.000262	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—TXN—glaucoma	6.15e-05	0.000262	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CA2—glaucoma	6.02e-05	0.000257	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	5.96e-05	0.000254	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—MTHFR—glaucoma	5.9e-05	0.000251	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—APOE—glaucoma	5.61e-05	0.000239	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GSTT1—glaucoma	5.61e-05	0.000239	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—CAV1—glaucoma	5.56e-05	0.000237	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—APOE—glaucoma	5.49e-05	0.000234	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—VEGFA—glaucoma	5.48e-05	0.000234	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	5.46e-05	0.000233	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—CAV1—glaucoma	5.44e-05	0.000232	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—CYP1B1—glaucoma	5.1e-05	0.000218	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	5.03e-05	0.000215	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—TXN—glaucoma	5e-05	0.000213	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GSTT1—glaucoma	4.77e-05	0.000203	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GSTT1—glaucoma	4.77e-05	0.000203	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—TNF—glaucoma	4.7e-05	0.0002	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	4.67e-05	0.000199	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—TXN—glaucoma	4.58e-05	0.000195	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CA5A—glaucoma	4.49e-05	0.000191	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NARFL—glaucoma	4.49e-05	0.000191	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ABCA1—glaucoma	4.47e-05	0.000191	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CYP1B1—glaucoma	4.47e-05	0.000191	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.36e-05	0.000186	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—TXN—glaucoma	4.24e-05	0.000181	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.18e-05	0.000178	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.14e-05	0.000177	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—NOS3—glaucoma	4.11e-05	0.000175	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—GSTM1—glaucoma	4.08e-05	0.000174	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	4.02e-05	0.000172	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GSTT1—glaucoma	3.88e-05	0.000165	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.85e-05	0.000164	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ABCA1—glaucoma	3.8e-05	0.000162	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CYP1B1—glaucoma	3.8e-05	0.000162	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CYP1B1—glaucoma	3.8e-05	0.000162	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ABCA1—glaucoma	3.8e-05	0.000162	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PTGS2—glaucoma	3.76e-05	0.00016	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GSTM1—glaucoma	3.57e-05	0.000152	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CA1—glaucoma	3.56e-05	0.000152	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GSTT1—glaucoma	3.55e-05	0.000151	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CTSA—glaucoma	3.45e-05	0.000147	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	3.43e-05	0.000146	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GSTT1—glaucoma	3.29e-05	0.00014	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CA2—glaucoma	3.25e-05	0.000139	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	3.25e-05	0.000139	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—MTHFR—glaucoma	3.16e-05	0.000135	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ABCA1—glaucoma	3.09e-05	0.000132	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CYP1B1—glaucoma	3.09e-05	0.000132	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GSTM1—glaucoma	3.04e-05	0.00013	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GSTM1—glaucoma	3.04e-05	0.00013	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—APOE—glaucoma	2.94e-05	0.000125	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CAV1—glaucoma	2.91e-05	0.000124	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.86e-05	0.000122	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ABCA1—glaucoma	2.83e-05	0.000121	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYP1B1—glaucoma	2.83e-05	0.000121	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	2.7e-05	0.000115	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—MTHFR—glaucoma	2.69e-05	0.000114	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—MTHFR—glaucoma	2.69e-05	0.000114	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP1B1—glaucoma	2.62e-05	0.000112	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ABCA1—glaucoma	2.62e-05	0.000112	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—APOE—glaucoma	2.5e-05	0.000107	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—APOE—glaucoma	2.5e-05	0.000107	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CAV1—glaucoma	2.48e-05	0.000106	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CAV1—glaucoma	2.48e-05	0.000106	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GSTM1—glaucoma	2.47e-05	0.000105	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.32e-05	9.88e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—TXN—glaucoma	2.29e-05	9.78e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GSTM1—glaucoma	2.26e-05	9.65e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—NOS3—glaucoma	2.2e-05	9.39e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CA1—glaucoma	2.19e-05	9.35e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—MTHFR—glaucoma	2.18e-05	9.3e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CTSA—glaucoma	2.12e-05	9.05e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GSTM1—glaucoma	2.09e-05	8.93e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.04e-05	8.71e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—APOE—glaucoma	2.03e-05	8.66e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTGS2—glaucoma	2.01e-05	8.59e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CAV1—glaucoma	2.01e-05	8.58e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CA2—glaucoma	2.01e-05	8.55e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—MTHFR—glaucoma	2e-05	8.52e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—NOS3—glaucoma	1.87e-05	7.98e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—NOS3—glaucoma	1.87e-05	7.98e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—APOE—glaucoma	1.86e-05	7.94e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—MTHFR—glaucoma	1.85e-05	7.89e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CAV1—glaucoma	1.84e-05	7.86e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTT1—glaucoma	1.78e-05	7.58e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—APOE—glaucoma	1.72e-05	7.35e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTGS2—glaucoma	1.71e-05	7.3e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTGS2—glaucoma	1.71e-05	7.3e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CAV1—glaucoma	1.71e-05	7.28e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—NOS3—glaucoma	1.52e-05	6.49e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP1B1—glaucoma	1.42e-05	6.04e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ABCA1—glaucoma	1.42e-05	6.04e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—TXN—glaucoma	1.41e-05	6.02e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—NOS3—glaucoma	1.39e-05	5.95e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTGS2—glaucoma	1.39e-05	5.93e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—NOS3—glaucoma	1.29e-05	5.5e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTGS2—glaucoma	1.28e-05	5.44e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTGS2—glaucoma	1.18e-05	5.03e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTM1—glaucoma	1.13e-05	4.83e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTT1—glaucoma	1.1e-05	4.67e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—MTHFR—glaucoma	1e-05	4.27e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APOE—glaucoma	9.32e-06	3.97e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CAV1—glaucoma	9.23e-06	3.94e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ABCA1—glaucoma	8.73e-06	3.72e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP1B1—glaucoma	8.73e-06	3.72e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NOS3—glaucoma	6.98e-06	2.98e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTM1—glaucoma	6.98e-06	2.97e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTGS2—glaucoma	6.39e-06	2.72e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MTHFR—glaucoma	6.17e-06	2.63e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APOE—glaucoma	5.74e-06	2.45e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CAV1—glaucoma	5.69e-06	2.43e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NOS3—glaucoma	4.3e-06	1.83e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTGS2—glaucoma	3.93e-06	1.68e-05	CbGpPWpGaD
